Discovery, Innovation, Growth
Park Square has placed David Pyott as Independent Director at Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel...…
Park Square has placed Parth Chakrabarti as Executive Vice Chancellor for Innovation and Business Development at UMass Medical School.
Parth Chakrabarti, MPH, MBA, an experienced strategic leader in the pharmaceutical and biotech industry, will serve as UMass Medical...…
Park Square has placed Amanda Kay, Ph.D., as Chief Business Officer at Deep Genomics.
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Amanda Kay, Ph.D., to...…
Park Square is delighted to announce the placement of Vanessa Taylor, Ph.D., as Head of Biology and Preclinical Development at Terray...
Park Square has placed Matthew Ferguson as Chief Financial Officer at Aziyo Biologics.
Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of...…
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
